Michael Klichinsky
Oprichter bij CARISMA THERAPEUTICS, INC.
Vermogen: 644 182 $ op 31-05-2024
Actieve functies van Michael Klichinsky
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CARISMA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-04-2022 | - |
| Oprichter | 01-01-2016 | - | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Hoofd Techniek/Wetenschap/O&O | 01-04-2022 | - |
| Oprichter | 01-01-2016 | - | |
| Corporate Officer/Principal | 01-10-2018 | 01-04-2022 |
Loopbaan van Michael Klichinsky
Opleiding van Michael Klichinsky
| University of Pennsylvania | Doctorate Degree |
| University of the Sciences in Philadelphia | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Doctorate Degree | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CARISMA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
- Beurs
- Insiders
- Michael Klichinsky
- Ervaring
